Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.280
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
1.270
-0.010 (-0.78%)
Pre-market: Apr 29, 2026, 7:08 AM EDT
Cognition Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 114 | 119 | 29 | 59 | 61 | 139 | |
| Market Cap Growth | 422.96% | 308.99% | -50.97% | -2.39% | -56.29% | - | |
| Enterprise Value | 78 | 80 | 8 | 27 | 15 | 216 | |
| Last Close Price | 1.28 | 1.35 | 0.70 | 1.85 | 2.10 | 6.32 | |
| PB Ratio | 3.32 | 3.48 | 1.55 | 2.43 | 1.51 | 2.72 | |
| P/TBV Ratio | 3.34 | 3.48 | 1.55 | 2.43 | 1.51 | 2.72 | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.04 | 0.05 | 0.04 | - | |
| Net Debt / Equity Ratio | -1.05 | -1.05 | -1.29 | -1.17 | -1.00 | -1.07 | |
| Net Debt / EBITDA Ratio | 0.76 | 0.76 | 0.45 | 0.57 | 0.92 | 1.92 | |
| Net Debt / FCF Ratio | 1.47 | 1.47 | 0.85 | 1.77 | 2.14 | 14.96 | |
| Quick Ratio | 3.36 | 3.36 | 2.49 | 3.07 | 5.80 | 7.25 | |
| Current Ratio | 3.45 | 3.45 | 2.65 | 3.37 | 6.11 | 7.50 | |
| Return on Equity (ROE) | -88.59% | -88.59% | -157.19% | -79.69% | -46.76% | -60.93% | |
| Return on Assets (ROA) | -75.99% | -75.99% | -103.15% | -74.08% | -49.69% | -53.95% | |
| Return on Capital Employed (ROCE) | -138.70% | -138.70% | -282.70% | -202.90% | -102.20% | -55.80% | |
| Earnings Yield | -20.54% | -19.71% | -116.59% | -43.40% | -35.15% | -8.41% | |
| FCF Yield | -21.50% | -20.63% | -97.74% | -27.20% | -30.72% | -2.63% | |
| Buyback Yield / Dilution | -83.15% | -83.15% | -32.31% | -27.03% | -355.42% | -921.60% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.